ClinicalTrials.gg
RecruitingNCT05987774Updated Aug 10, 2026

Improving Social Communication in Individuals With ASD Using AI

An interventional study of AI Modules for Improving Social Communication in Autism Spectrum Disorder, sponsored by Stanford University. Recruiting at 1 site in United States. Open to participants aged 3 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-08-10.

Primary conditionAutistic DisorderRegistry: Autism Spectrum DisorderReclassifiedWhy we changed it
Registry
Autism Spectrum Disorder — the first condition term the registry derived for this study.
ClinicalTrials.gg
Autistic Disorder
Why
  1. The study's listed conditions name Autistic Disorder, a narrower term within Autism Spectrum Disorder.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Stanford University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Oct 2023; still recruiting 3 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
540
Allocation
Randomized
Ages
3 Years to 35 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 33 studies in Autistic Disorder by Stanford University — 16 open to participants now, 16 under way, none of them phase 3. Autistic Disorder · Stanford University.

Planned enrollment
3rd of 33
540 · median 48
Started
2023
with 5 others
No phase
21 of 33
11 open now
Primary completion
2027-06
later than 3 of 15 live
Registered
26th of 33
by date

Among the 33 studies in Autistic Disorder by Stanford University, this one is the 3rd largest by planned enrollment, is one of 6 that started in 2023, is one of 21 with no phase, reaches primary completion later than 3 of the 15 other live ones, and was the 26th registered.

Autistic Disorder

1,035 studies on the registry are indexed under Autistic Disorder; 270 are open to participants now.

Browse Autistic Disorder studies →

Open to participants now

16 of the 33 studies in Autistic Disorder by Stanford University are open now, in 1 country. Recruiting first, the newest first:

10 more — sign in →

By country, each count listing its studies:

All 16 open studies →

Where they have run

Who these studies take

Of the 184 Autistic Disorder studies recruiting now, 33 (18%) set no upper age limit and 144 (78%) stop at 75 or younger; 150 take children under 18; 56 take healthy volunteers.

This study: 3 Years to 35 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 33 studies in Autistic Disorder by Stanford University, or all of them as a file.
02

Study summary

The purpose of this study is to identify whether researched and commonly used face-to-face interventions can be effectively implemented through artificial intelligence (AI) using an application on the phone or computer. The investigators plan to recruit individuals diagnosed with autism spectrum disorder who demonstrate challenges with social communication. Modules focusing on various difficulties experienced by autistic individuals will provide practice and feedback using voice recognition and feedback. If effective, this intervention can be scaled up to provide cost-effective accessible assistance to individuals, particularly those who do not have access to care or prefer to secure services in the comfort of their own homes.

Read the detailed description

Intervention has been proven effective to improve interpersonal and communication skills for people with low social awareness or certain neurological conditions such as autism spectrum disorder. However, the application of this type of trainings is limited due to the lack of trained clinicians, the difficulties in finding/creating social settings, and the cost of ongoing treatments, among other factors. In this study, the investigators hope to elucidate whether autistic individuals will benefit from the translation of face-to-face interventions delivered by AI application (app) that can be easily accessed on the phone or computer.

For the last decades, the world has experienced a geometric increase in the number of individuals diagnosed with autism spectrum disorder, with the CDC reporting that 1 in 31 individuals now being diagnosed with the condition. With such large numbers, individuals in need of intervention services face long clinical wait times along with a shortage of trained providers. From this study, the investigators aim to learn whether AI programs that do not require the labor-intensive face-to-face clinician hours are effective in improving the social communication of autistic individuals.

The investigators anticipate that in just 4 weeks of short daily (weekdays) practice sessions with the app, the treatment groups will show improvements in areas that are generally challenging for this population and adolescents and adults will report more confidence during social conversation compared to the waitlist control groups. The investigators are requesting that participants complete a minimal number of intervention trials, with the option of completing more if desired. Should participants vary in their improvement based on intervention time, this information should assist with understanding an optimal level of intervention for effectiveness. The investigators will carefully document percentage correct for each module, time spent on the module, and improvement.

The investigators will match adult participants who are within 5 years of age. Adolescents and young children will not be matched but will be divided equally into two groups. The investigators anticipate no change in the wait list control groups.

The purpose of this study is to examine the efficacy of Artificial Intelligence (AI) intervention using an application for autistic individuals; therefore, human subjects need to be used for this project.

The intervention our Artificial Intelligence (AI) app targets has already been developed and is based on face-to-face research studies. The study will recruit autistic adults, adolescents, and young children from the community and will assess the effects of using artificial intelligence to practice social conversation.

Our staff will have a single phone/Zoom contact with potential autistic participants and/or parents wishing to enroll in the online training intervention to complete a brief screening before completing informed consent documents electronically through Adobe Sign. Participants must have a primary diagnosis of autism spectrum disorder to participate. Adolescent and adult participants must be able to understand and converse in complete sentences.

Parents of potential adolescent participants and potential participants will complete a password-protected 10-20 minute phone/Zoom screening (Zoom is safe for PHI) to determine whether their child/they are eligible for the study.

For adolescents, during the last five minutes of the phone/Zoom screen, research personnel will invite the adolescent to join in a brief conversation. The researcher's goal is to assess behavior and compliance. Research personnel conducting the screen will ask everyday conversational questions. During the Zoom screening, research personnel will answer any of the potential participants' and their parents' questions. The parent's' and potential participants' responses will be recorded in REDCap (database is safe for PHI). Adult and adolescent potential participants who are not able to carry on a conversation or who express a lack of interest in the study/intervention will be excluded from the study.

Participants who are not excluded during the phone/Zoom screen will be consented. After consenting, in lieu of conducting autism diagnostic assessments, the investigators will request a confirmation of an autism diagnosis or release of information from the medical doctor, psychologist, or other specialist that provided the formal diagnosis of autism spectrum disorder. This can be uploaded securely on REDCap by the participant in lieu of testing. Additionally, the investigators will request information on participant characteristics including current age, age of diagnosis, co-occurring diagnosis, ethnicity, and gender (for the latter two categories there will be an option of "prefer not to answer"), employment status, and number of social events engaged in per week for each adolescent and adult participant. Parents of young children will also be asked to complete a survey related to their child's current services and screen time.

Participants with common co-occurring conditions such as depression and anxiety will not be excluded. This information may help us to understand if any co-occurring conditions may affect the results of the study.

The investigators will match adult participants who are within 5 years of age and then will randomly draw one name for the treatment group and one for the wait list group. Adolescents and young children will not be matched but will be divided equally into either the experimental group or the wait list control group.

Baseline Assessment:

Following informed consent/assent, the investigators will establish eligibility based on review of records confirming the diagnosis of autism and inclusion criteria (i.e., ASD diagnosis, willingness to participate, conversational (for adolescents/adults) needing intervention based on low scores during the communication sample, or communication delays for young children).

Eligible participants will be asked to chat or interact with a parent while the investigators record a 15- to 20-minute communication sample (depending on how much talking the potential participant engages in).

Communication Sample (to be collected pre and post intervention). For both the treatment and wait list control groups. The communication sample will include a natural interaction with someone who is aware of the experiment and will probe for targeted areas (e.g., for the Empathy module the examiner will say statements such as "I'm feeling a little under the weather today" to evoke an empathetic response). At least 5 opportunities will be provided for the targeted area (e.g., empathy, taking the right amount, asking relevant questions).

The communication sample will be recorded and saved on Stanford Medicine Box with a code name (with no identifying participant information). Each response relevant to the study will be scored. Participants who respond at 60% or higher during the communication sample will not be included in the study as they are not in a range that warrants intervention. Young children who do not show communication delays will not be included.

Comfort Scale. Prior to the start of intervention, the investigators will ask each adult and adolescent participant who scores below 60% and is eligible for participation to fill out a brief survey relating to their comfort in social situations (see pre- post questionnaire attachment - AI scale).

Standardized Test of Vocabulary. Parents of young children will be asked to complete a standardized measure of their child's words (i.e., the MacArthur-Bates Web-CDI) collected at pre- and post-intervention. The MacArthur Bates Web-CDI is an online parent-report assessment of their child's vocabulary (parents simply mark a check for words that their child says).

Checklist of Targeted Vocabulary. Parents of young children will be asked to fill out a checklist of the (approximately 250) target words included in the First Words Module.

DESIGN. This is a four-week randomized clinical trial (RCT). Three groups of 30, one for young children (ages 3-10), one for the adolescent group (age 11-18), and a third for adults (18-35) will be included. For each module, fifteen will participate in intervention immediately after completing baseline measures and fifteen will be placed in a wait list control group. Both groups will repeat the baseline measures (communication sample and comfort scale) again after 4 weeks.

We will also include a pilot study arm. Participants will be added as their baselines are stable and staggered according to multiple baseline design protocol.

Each RCT participant in the treatment group will be asked to participate for 4 weeks, at least 10-20 trials a day, for at least 5 days per week. The investigators anticipate that each session will take about ten minutes (unless the participant completes additional practice). Our AI system will record the number of trials and the length of time each participant engaged in the modules.

Intervention: The application will be delivered through a webapp. These modules have been developed to provide feedback on specific areas following voice or text input (user preference will be recorded in case this effects the results).

The investigators currently have developed AI modules for common social communication challenges exhibited by individuals with ASD. Examples include:

Learning First Words, Empathy (general and in the work setting), Asking Relevant Questions, Listen and Respond, Talking the right amount, Giving the Right Amount of Personal Information, Tactful Responses, Giving Compliments, and Staying on Topic

During Conversation. These are all areas that can be challenging for individuals diagnosed with autism spectrum disorder.

AI modules consist of thousands of total training examples. Participants may access the modules on their phones or computers.

Each module will contain groups of 10-20 training examples, and the participants' verbal responses will be analyzed and feedback provided.

Post Intervention:

Social Communication Sample. Following four weeks of intervention, an identical communicaiton sample will be collected in exactly the same manner as the baseline. Again, the communication samples collected via Zoom will be recorded and computer transcribed, after which recordings will be erased.

Standardized Test of Vocabulary. Following four weeks of intervention, parents of young children will be asked to complete the same standardized measure of their child's words that was collected at baseline (i.e., the MacArthur-Bates Web-CDI).

Checklist of Targeted Vocabulary. Following four weeks of intervention, parents of young children will be asked to fill out the same checklist of the (approximately 250) target words included in the First Words Module that was collected at baseline.

Comfort and Acceptability Survey. Following intervention, adolescent and adult participants in the treatment and wait list control group will be asked to complete a survey relating to their comfort in social situations. This includes the questions asked initially along with four additional questions related to the intervention (for participants in the treatment group). Parents of young children will only be asked questions related to the acceptability of the intervention.

For any participants who do not reach the 80% criterion during the four weeks of intervention and who do not meet an 80% criterion during the communication sample, and who wishes to receive additional intervention, an additional four weeks will be provided and the communication sample will be repeated after an additional four weeks. If no improvement occurs after the 8 weeks, they will be considered "nonresponders."

03

Conditions studied

  • Autism Spectrum Disorder

Browse trials for

Keywords

  • AI
  • autism
  • LLMs
  • GPT
  • social skills
  • autism support
  • autism spectrum disorder
04

In context

Autistic Disorder Reclassified

1,035 studies on the registry are indexed under Autistic Disorder; 270 are open to participants now.

This study's planned enrollment of 540 is above the median of 50 across 814 interventional studies indexed under Autistic Disorder.

Browse Autistic Disorder studies →

Lead sponsor

Stanford University is the lead sponsor of 2,171 studies on the registry; 425 are open to participants now.

Of its 268 completed or terminated interventional studies of FDA-regulated products, 207 (77%) have results posted.

Compared within Autistic Disorder, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Autism Spectrum Disorder. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
3 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Primary diagnosis of autism spectrum disorder (ASD)
  • Age of adolescents and adults: between 11-35 years
  • Age of minimally verbal children: between 3-5 years
  • Ability to engage in social conversation using full sentences for a 20-minute period (adolescents and adults)
  • Verbal communication difficulties in an individual targeted area (e.g., empathy) as measured on the communication sample

Participants with a co-occuring diagnosis of ADHD, depression, or social anxiety will not be excluded since these are very common in this population and are often related to or a bi-product of difficulties with social communication.

Exclusion criteria

Exclusion Criteria:

  • Non-documented or self-diagnosis of ASD
  • At or above 60% correct responding on targeted area of social conversation during conversation probe (adolescents and adults)
  • No significant language delay (young children)
  • No access to phone or computer for intervention sessions
  • Inability to carry on a conversation during the conversation probe
  • Apparent intellectual impairment that interferes with the ability to carry on a conversation (e.g., responds only in single words or does not respond to conversation, lack of understanding of questions or content during conversation probe)
  • Non-English speaking
  • Serious medical or psychiatric issues that may interfere with conversation or the ability to complete the program
  • Lack of interest in participating.
06

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
540 participants (estimated)

Study arms

  • Experimental
    Intervention Group

    This group will receive the treatment (AI conversation modules) available through the application.

    Device: AI Modules for Improving Social Communication

  • No intervention
    Control Group

    This waitlist control group will not receive treatment until the experimental group completes their intervention.

Interventions

  • DeviceAI Modules for Improving Social Communication

    The modules will be accessed via a web app. These modules have been developed to provide feedback on specific areas following voice or text input (user preference will be recorded in case this effects the results). The investigators currently have developed AI modules for common social communication challenges exhibited by individuals with ASD. Examples include: Learning First Words, Empathy (general and in the work setting), Asking Relevant Questions, Listen and Respond, Talking the Right Amount, Giving the Right Amount of Personal Information, Tactful Responses, Giving Compliments, and Staying On Topic During Conversation. These are all areas that can be challenging for individuals diagnosed with autism spectrum disorder. AI modules consist of thousands of total training examples. Participants may access the modules on their phones, tablets, or computers.

07

What researchers measure

Primary outcomes

  1. Social Communication Sample

    Measured in terms of what percentage of responses (0% - 100%) during the investigators' social conversation sample are answered appropriately for adolescents and adults or number of spoken words for young children. Each of the participants' responses will be evaluated by a MA or PhD-level expert. Social communication samples will be collected via Zoom, recorded and computer transcribed, after which recordings will be erased. An initial sample will be collected at baseline, after four weeks of intervention, and at post-intervention.

    Time frame: Approximately 5-9 weeks per participant (4 weeks of intervention + pre and post measures + for adolescents and adults 1-month follow-up.)

Secondary outcomes

  1. Social Validity Scale

    Likert scale that ranges from 1 - 5. 1 is the minimum value (the worst outcome) and 5 is the maximum value (the best outcome). Prior to and following intervention, adolescent and adult participants in the treatment and wait list control group will be asked to complete a self-evaluated survey relating to their comfort in social situations. Participants in the treatment group (including parents of young children) will also be asked to fill out a Likert scale relating to their satisfaction with the intervention.

    Time frame: Approximately 5-6 weeks

  2. Standardized Test of Vocabulary

    Parents of young children will be asked to complete a standardized measure of their child's words (i.e., the MacArthur-Bates Web-CDI) collected at pre- and post-intervention. The MacArthur Bates Web-CDI is an online parent-report assessment of their child's vocabulary (parents simply mark a check for words that their child says).

    Time frame: Approximately 4-5 weeks per participant

  3. Checklist of Targeted Vocabulary

    This measure is a checklist of the (approximately 250) target words included in the First Words Module that asks parents of young children to indicate if their child understands, understands and says, says but does not understand, or does not say or understand the word. This will be given to parents of young children pre- and post-intervention.

    Time frame: Approximately 4-5 weeks per participant

08

Study locations

1 of 1 sites recruiting
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2023 (actual). Primary completion is estimated for Jun 2027, 44 months after the start.

Of 355 non-industry interventional studies with no phase under Autistic Disorder, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 50. This study's planned 44 months is above that.

Counting every sponsor, half of 367 studies reached it within 26 months; a quarter within 13 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 26, 2023
First posted
Aug 14, 2023
StartActual
Oct 15, 2023
Primary completionEst.
Jun 30, 2027
CompletionEst.
Jun 30, 2050
Last update
Aug 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05987774
Responsible party
Lynn Koegel (Clinical Professor, Stanford University) — Principal investigator
First posted
Aug 14, 2023
Start date
Oct 15, 2023
Primary completion
Jun 30, 2027 (estimated)
Completion
Jun 30, 2050 (estimated)
Last update
Aug 10, 2026

Study contacts

Lynn K Koegel, PhD
Contact
lynnk@stanford.edu
8056899493
Monica Lam, PhD
Contact
lam@stanford.edu
6502240595

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion